nitroglycerin has been researched along with tetradecanoylphorbol acetate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gross, GJ; Pieper, GM | 1 |
Alonso, MA; López-Guerrero, JA | 1 |
Athar, M; Sharma, N; Trikha, P | 1 |
Broch, M; Castro, A; Engel, P; Fernandez-Real, JM; Lainez, B; Peñarroja, G; Pérez, A; Ricart, W; Richart, C; Rigla, M; Vendrell, J | 1 |
4 other study(ies) available for nitroglycerin and tetradecanoylphorbol acetate
Article | Year |
---|---|
Anti-free-radical and neutrophil-modulating properties of the nitrovasodilator, nicorandil.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Free Radical Scavengers; Free Radicals; Glyburide; Hydroxides; Hydroxyl Radical; In Vitro Techniques; Neutrophils; Niacinamide; Nicorandil; Nitroglycerin; Opsonin Proteins; Superoxides; Tetradecanoylphorbol Acetate; Vasodilator Agents | 1992 |
Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells.
Topics: Cell Differentiation; Cell Line; Cell Survival; Herpesvirus 1, Human; Humans; Nitric Oxide; Nitroglycerin; omega-N-Methylarginine; Tetradecanoylphorbol Acetate; Virus Replication | 1997 |
Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin.
Topics: Animals; Carcinogens; Mice; Nitric Oxide Donors; Nitroglycerin; Papilloma; Skin Neoplasms; Tetradecanoylphorbol Acetate | 2001 |
Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Topics: Adult; Aged; Antigens, CD; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Flow Cytometry; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Monocytes; Nitroglycerin; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Solubility; Tetradecanoylphorbol Acetate; Vasodilation | 2002 |